TRICORT 40MGML INJECTION
Negara: Malaysia
Bahasa: Inggris
Sumber: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)
Karakteristik produk
(SPC)
17-03-2023
Beberapa dokumen untuk produk ini saat ini tidak tersedia, Anda dapat mengirim permintaan ke layanan pelanggan kami dan kami akan memberi tahu Anda segera setelah kami bisa mendapatkannya.
Kirim permintaan.
Kirim permintaan.
Bahan aktif:
TRIAMCINOLONE ACETONIDE
Tersedia dari:
PAHANG PHARMACY SDN. BHD.
INN (Nama Internasional):
TRIAMCINOLONE ACETONIDE
Unit dalam paket:
1 Vials
Diproduksi oleh:
CADILA PHARM LTD
Karakteristik produk
BACK SIDE
Pheochromocytoma crisis, which may be fatal, has been reported after
administration of systemic corticosteroids. Corticosteroids
should only be administered to patients with suspected or identified
pheochromocytoma after an appropriate risk/benefit evaluation.
OXXXXXXX
1389, Trasad Road, Dholka-382225,
Dist: Ahmedabad, Gujarat State, India. DATE OF REVISION:
15th March 2023
CO-TREATMENT WITH CYP3A INHIBITORS,
including cobicistat-containing products, is expected to increase the
risk of systemic side-
effects. The combination should be avoided unless the benefit
outweighs the increased risk of systemic corticosteroid side-effects,
in
which case patients should be monitored for systemic corticosteroid
side-effects.
Size : 120 x 400 mm
Export : Malaysia
Pantone P Black C
DG-15/03/23-V06
DG-18/11/22-V05
DG-28/07/22-V04
DG-21/07/22-V03
SS-29/11/18-V02
HV-10/10/16-V01
Baca dokumen lengkapnya
